Team:UC Davis

From 2009.igem.org

(Difference between revisions)
(Overview)
(Overview)
Line 17: Line 17:
We are confident that our two systems can be built in time to present to the iGEM community.
We are confident that our two systems can be built in time to present to the iGEM community.
-
[[https://2009.igem.org/Team:UC_Davis/About_Us About Us]] [[https://2009.igem.org/Team:UC_Davis/Celiac Celiac Disease]] [[https://2009.igem.org/Team:UC_Davis/Treatments Current Treatment]] [[https://2009.igem.org/Team:UC_Davis/Approach Our Approach]] [[https://2009.igem.org/Team:UC_Davis/pH_Sensor pH Sensor]] [[https://2009.igem.org/Team:UC_Davis/pH_Sensor/parts pH Sensor Parts]]
+
[[https://2009.igem.org/Team:UC_Davis/About_Us About Us]] [[https://2009.igem.org/Team:UC_Davis/Celiac Celiac Disease]] [[https://2009.igem.org/Team:UC_Davis/Treatments Current Treatment]] [[https://2009.igem.org/Team:UC_Davis/Approach Our Approach]] [[https://2009.igem.org/Team:UC_Davis/pH_Sensor pH Sensor]] [[https://2009.igem.org/Team:UC_Davis/pH_Sensor/parts pH Sensor Parts]] [[https://2009.igem.org/Team:UC_Davis/pH_Sensor/promoters pH Promoters]]

Revision as of 04:03, 22 September 2009

Overview

It is estimated that about one in every 133 Americans suffer from an autoimmune disorder called Celiac Disease (14, 11). Celiac Disease is a condition where the small intestines of an affected individual cannot digest gliadin, a protein present in gluten. When consumed, gliadin kick starts immune system responses, whose side-effects are, but not limited to abdominal pain, chronic diarrhea and vomiting (14). One of our teammate’s friends is currently suffering from this illness, which interested us to look into Celiac Disease as the focus of our project. Currently, the only accepted treatment for this disorder is adhering to a gluten-free diet (14, 12). This can be very difficult as great varieties of food contain gluten. This inspired us to design a probiotic organism that could survive and take residence in the stomach where it would secrete an enzyme that can degrade gliadin.

This synthetically engineered bug should be able to satisfy at least two main criteria. First, it should be able to survive ONLY in the stomach and, secondly, secrete an enzyme that can degrade gliadin.

Studies have shown that the enzyme, Prolyl-endoprotease is able to degrade gliadin at the pH level of the stomach (8). Prolyl-endoprotease is one of the most promising enzymes which being used in recent studies regarding celiac disease treatment.

Due to licensing restrictions, we have opted not to work with this protein.

We have decided to focus our summer project on building two key elements required for our “dream bug”. Therefore, our project has been split into two tasks:

  1. Produce an inducible secretion system
  2. Construct a biological pH sensor limiting this secretion system to the stomach

This pH system will be sensitive to the change in pH when the probiotic leaves the stomach. We are confident that our two systems can be built in time to present to the iGEM community.

[About Us] [Celiac Disease] [Current Treatment] [Our Approach] [pH Sensor] [pH Sensor Parts] [pH Promoters]